Monitor for further Lind note conversions and the pricing/outcome of the pending best-efforts offering. Continued dilution and cash burn suggest the stock will remain under pressure until the company demonstrates a path to revenue or a financing solution.
Price Chart
Executive Summary
VolitionRx issued 545,591 shares to Lind Global Asset Management in two tranches (May 19 and June 17, 2026) to satisfy $833,332 in payment obligations under a $7.5M convertible note. This dilutive debt conversion adds to existing share overhang and occurs alongside two recent best-efforts offerings (424B5 filings on June 5 and June 9) that signal acute cash needs. The company has a going-concern opinion and negative tangible book value, making this another bearish data point for the micro-cap diagnostics stock.
Key Facts
- 333,332 shares issued on June 17, 2026 to satisfy a $416,666 payment obligation to Lind
- 212,259 shares issued on May 19, 2026 to satisfy a $416,666 payment obligation to Lind
- Total of 545,591 shares issued in two tranches for $833,332 in debt repayment
- Shares issued under Section 3(a)(9) or 4(a)(2) exemptions, no commissions or public offering
- Two recent 424B5 filings (June 5 and June 9) indicate simultaneous capital raises in distressed conditions
Financial Impact
$833,332 in payment obligations satisfied via 545,591 shares; implied dilution of approximately 6-7% of outstanding shares based on $12M market cap
Risk Factors
- Further dilution from remaining Lind note balance (~$6.7M)
- Inability to complete the best-efforts offering
- Going-concern risk and negative tangible book value
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001477932-26-003932 |
| Document: 0001477932-26-003932-index-headers.html | 0001477932-26-003932 |
| Document: 0001477932-26-003932-index.html | 0001477932-26-003932 |
| Document: 0001477932-26-003932.txt | 0001477932-26-003932 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $0.1900 | awaiting T+60 | — | $0.1900 (−0.00%) |
Sep 25, 2026 4w ago | 8-K | $0.2529 | awaiting T+60 | — | $0.1900 (+24.87%) |
Sep 16, 2026 5w ago | SC 13D/A | $0.2849 | awaiting T+60 | — | $0.1900 (−33.31%) |
Sep 15, 2026 6w ago | 8-K | $0.2749 | awaiting T+60 | — | $0.1900 (+30.88%) |
Sep 11, 2026 6w ago | EFFECT | $0.3102 | awaiting T+60 | — | $0.1900 (+38.75%) |
Sep 8, 2026 7w ago | S-3/A | $0.3400 | awaiting T+60 | — | $0.1900 (+44.12%) |
Sep 1, 2026 8w ago | 8-K | $0.3800 | awaiting T+60 | — | $0.1900 (+50.00%) |
Aug 24, 2026 9w ago | 8-K | $0.3846 | awaiting T+60 | — | $0.1900 (+50.60%) |
Aug 7, 2026 11w ago | 8-K | $0.7700 | awaiting T+60 | — | $0.1900 (+75.32%) |
Jul 20, 2026 14w ago | EFFECT | $1.13 $0.1847 | ▲ +83.65% | ▲ +88.50% | $0.1900 (+83.19%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers